A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study.
J Infect Dis
; 218(3): 378-387, 2018 07 02.
Article
en En
| MEDLINE
| ID: mdl-29617814
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Proteínas Oncogénicas de Retroviridae
/
Adyuvantes Inmunológicos
/
Virus Sincitial Respiratorio Humano
/
Infecciones por Virus Sincitial Respiratorio
/
Vacunas contra Virus Sincitial Respiratorio
/
Lípidos
/
Anticuerpos Antivirales
Tipo de estudio:
Clinical_trials
Límite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2018
Tipo del documento:
Article